Open AccessProspective Study of Amphotericin B Formulations in Immunocompromised Patients in 4 European Countries
Author(s) -
Andrew J. Ullmann,
Miguel Á. Sanz,
Andrea Tramarin,
R.A. Barnes,
Weizhou Wu,
B. Gerlach,
Karl J. Krobot,
W.C. Gerth
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/505969
Subject(s) - medicine , amphotericin b , prospective cohort study , intensive care medicine , antifungal , dermatology
Amphotericin B is a widely used broad-spectrum antifungal agent, despite being associated with significant adverse events, including nephrotoxicity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom